Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer's disease Scripps Research scientists created a stable form of carnosic acid, observing greater memory function and other disease improvements in mice.
March 10, 2025
LA JOLLA, CA The herb rosemary has long been linked with memory: There's rosemary, that's for remembrance, says Ophelia in Shakespeare's Hamlet. So it is fitting that researchers would study a compound found in rosemary and sage carnosic acid for its impact on Alzheimer's disease. In the disease, which is the leading cause of dementia and the sixth leading cause of death in the US, inflammation is one component that often leads to cognitive decline.
Carnosic acid is an antioxidant and anti-inflammatory compound that works by activating enzymes that make up the body's natural defense system. While pure carnosic acid is too unstable to be used as a drug, scientists at Scripps Research have now synthesized a stable form, diAcCA. This compound is fully converted to carnosic acid in the gut before being absorbed into the bloodstream.
The research, published in Antioxidants on February 28, 2025, showed that when diAcCA was used to treat mouse models of Alzheimer's disease, it achieved therapeutic doses of carnosic acid in the brain and led to enhanced memory and synaptic density, or more synapses (representing the connections between nerve cells), in the brain. Because the decline of neuronal synapses is also closely correlated to dementia in Alzheimer's disease, this approach could counteract the progression of cognitive decline.
Analysis of tissue samples showed the drug also markedly decreased inflammation in the brain. This unique drug is activated by the very inflammation that it then combats and thus is only active in areas of the brain undergoing inflammatory damage. This selectivity limits the potential side effects of carnosic acid, which is on the US Food and Drug Administration's generally regarded as safe (GRAS) list, easing the way for clinical trials.
By combating inflammation and oxidative stress with this diAcCA compound, we actually increased the number of synapses in the brain, says senior author and professor Stuart Lipton, MD, PhD, the Step Family Foundation Endowed Chair at Scripps Research and a clinical neurologist in La Jolla, California. We also took down other misfolded or aggregated proteins such as phosphorylated-tau and amyloid- , which are thought to trigger Alzheimer's disease and serve as biomarkers of the disease process.
Lipton's group had previously determined that carnosic acid crosses the blood-brain barrier and activates the Nrf2 transcriptional pathway, which turns on antioxidant and anti-inflammatory genes. But the compound oxidizes easily, making it unsuitable as a drug because of its short shelf-life.
In this new study, Lipton and co-author Phil Baran, PhD, the Dr. Richard A. Lerner Endowed Chair in the Department of Chemistry at Scripps Research, synthesized a range of carnosic acid derivatives and selected diAcCA as the best candidate because of its stability, bioavailability, and other drug-like properties. Lipton's group then treated mouse models with the compound over the course of three months. The group examined the mice by testing their spatial learning and memory in behavioral tests and then analyzing brain tissue under the microscope.
We did multiple different tests of memory, and they were all improved with the drug, Lipton says. And it didn't just slow down the decline; it improved virtually back to normal. Analysis of tissues also showed increased neuronal synaptic density and decreased formation of phosphorylated-tau aggregates and amyloid- plaques.
The mice tolerated diAcCA well. In toxicity studies, the compound even soothed baseline inflammation in the esophagus and stomach as it was converted to carnosic acid.
The group also found that the mice took up about 20% more carnosic acid after ingesting diAcCA than they did after taking plain carnosic acid. Because most carnosic acid oxidizes while being stored or upon ingestion, diAcCA produces more carnosic acid in the blood than if you took carnosic acid itself, Lipton explains.
Lipton sees a potential for diAcCA to work in tandem with Alzheimer's treatments currently on the market. Not only could the drug work on its own by combating inflammation, but it could make existing amyloid antibody treatments work better by taking away or limiting their side effects such as a form of brain swelling or bleeding known as ARIA-E and ARIA-H, he says.
Lipton hopes diAcCA can be fast-tracked through clinical trials because of its safety profile. He thinks it could also be explored as a treatment for other disorders marked by inflammation, such as type 2 diabetes, heart disease, and other forms of neurodegeneration such as Parkinson's disease.
In addition to Lipton and Baran, authors of the study diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer's Disease include Piu Banerjee, Yubo Wang, Lauren N. Carnevale, Parth Patel, Charlene K Raspur, Nancy Tran, Xu Zhang, and Amanda J. Roberts of Scripps Research and Ravi Natarajan of Socrates Biosciences.
This work was supported by funding from the National Institutes of Health (U01 AG088679, R01 AG056259, R35 AG071734, RF1 AG057409, R01 AG056259, R56 AG065372, R01 DA048882, DP1 DA041722 and S10 OD030332).
Neuroscience Lipton, Stuart
Europe Stories
06/10/2025
France T l visions, France's leading broadcaster, has received the 2025 EBU ...
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
07/08/2025
July 8 2025, 22:30 (PDT) Tata Motors & Dolby Bring Dolby Atmos to Harrier.ev, R...
11/07/2025
If you've ever wondered what might be playing in Clark Kent's headphones...
11/07/2025
AI and Multimedia Authenticity Standards Collaboration launches two papers to guide the future of AI integration, today at the AI for Good Global Summit
The...
10/07/2025
The current holder of the prestigious Thomson Foundation Young Journalist of the Year Award has been forced to stop reporting over fears for her safety in Afgha...
10/07/2025
Spotify is turning up the volume on Australian music with a multipronged initiative designed to highlight the dominance of Australian artists on the global stag...
10/07/2025
This is not a drill: Oasis is back on the road-marking its first live performanc...
10/07/2025
The music industry depends on fresh ideas, bold voices, and emerging talent. Yet across the U.K., too many young musicians lack the space to develop their craft...
10/07/2025
10 Jul 2025
VEON and Cohen Circle Secure Investor Commitments for Kyivstar Listing Kyiv, New York, Dubai, and Philadelphia - July 10, 2025 - VEON Ltd. (Nasdaq:...
10/07/2025
Thursday 10 July 2025
The Very Small Creatures
Jaime's Treetop Tales
Emerald
BooSnoo! Christmas Mashup
Pip & Posy's Spooktacular Party
The Very Sm...
10/07/2025
Thursday 10 July 2025
Brand new rewards are coming to Sky customers, with free ...
10/07/2025
Comscore Achieves Full JIC Certification for National TV Measurement Including...
09/07/2025
Wednesday 9 July 2025
Sky Broadband now has the UK's fastest broadband spee...
09/07/2025
CUPERTINO, CALIFORNIA Apple today announced Jeff Williams will transition his role as chief operating officer later this month to Sabih Khan, Apple's senior...
08/07/2025
In an era where digital threats to journalists are becoming increasingly aggressive and widespread, MediaSafe Africa launches as a vital online resource to help...
08/07/2025
This summer, as the energy builds for one of the biggest moments in women's ...
08/07/2025
UKTV today announces that Richard Watsham, Chief Creative Officer at UKTV and Global Director of Acquisitions for BBC Studios/UKTV, has decided to step down fro...
08/07/2025
SAN JOSE, Calif. - July 8, 2025 - Harmonic (NASDAQ: HLIT) today announced a reco...
08/07/2025
Arvato Systems Optimizes Customer Communication with AOK Niedersachsen
New project in the statutory health insurance sector
Arvato Systems and AOK Niedersach...
08/07/2025
On August 7, Apple Arcade is adding four exclusive games to its diverse catalogue of more than 200 fun games for players to enjoy, all free from ads and in-app ...
07/07/2025
** MEDIA ALERT **
VIZ Media Ignites AX 2025 with Star-Studded Panels, Exclus...
07/07/2025
CULVER CITY, CALIFORNIA As Apple Music marks its 10th anniversary this year, Apple unveils its most ambitious creative project to date: a brand-new state-of-the...
07/07/2025
RT has announced that Mark Bignell has been appointed Commissioning Editor for Comedy following a public competition. This senior editorial position will drive...
04/07/2025
The Summer Reading Challenge has inspired children across the U.K. to embrace a ...
04/07/2025
Friday 4 July 2025
Watch the trailer here https://youtu.be/Od5WpvWmDr8
Further...
04/07/2025
The Pitch comes to RT Radio 1 airwaves this Sunday at 7pm. The Pitch is a brand...
03/07/2025
For our Vario-Jib, as well as for a repertoire of weights, we now have carts that make transport easier...
03/07/2025
One of our latest innovations: Slider Drive Unit!
Our Vario Slider not only comes with improvements and new features, but also with its own drive unit!
Our i...
03/07/2025
The 360 EVO lives up to its name: 360-degree rotation not only on the pan axis, but also on the roll axis, enables filmmakers to take their creative visions eve...
03/07/2025
What a buzzing few days at BSCExpo in London!
We were thrilled to connect with so many talented professionals from the world of cinematography.
A huge thank ...
03/07/2025
ADOLESCENCE - Shot with Panther Tower"The whole rig had to be detachable mid-episode
Netflix limited drama series Adolescence has been gaining attentio...
03/07/2025
** MEDIA ALERT ** Shonen Jump Store Hosting Los Angeles Pop-up During Anime Exp...
03/07/2025
Thursday 3 July 2025
David Harewood and Matthew Broome in Mozart: Genius for Hi...
03/07/2025
The Sky WNT Fund supports Womens National Team players with a 30,000 bursaryThursday 3 July 2025
Sky Ireland has announced the four recipients of the 2025 Sky...
02/07/2025
Calrec expands ecosystem at NAB 2025 giving broadcasters access to dynamic workflows and ultimate flexibility Helping broadcasters meet the shifting needs of me...
02/07/2025
02 Jul 2025
VEON Raises USD 200 Million in Private Bond Placement Dubai, July 1, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator ( VEON ), announces ...
02/07/2025
Brand new factual series follows mechanic and self-taught engineer Dom Chinea as he makes the move of his life to the far west of Cornwall
UKTV today announces...
02/07/2025
Rohde & Schwarz acquires ZES ZIMMER Electronic Systems GmbH and expands its T&M ...
02/07/2025
Wuppertal July 2, 2025
Riedel Communications Launches RefSuite Ecosystem for S...
02/07/2025
Andrew will serve as Chair of ABC alongside his role at NED, APL Media, where he supports the executive team with strategic insight and global expansion plans. ...
01/07/2025
The launch of Code of Silence, coupled with the Britains Got Talent semi final, gave ITV its best Sunday night of 2025.
The first episode of the new crime dr...
01/07/2025
ITV and Mammoth Screen have announced the start of filming for Betrayal, a gripp...
01/07/2025
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
01/07/2025
Vocal-processing plug-in joins NOIZ Hub series
Launched in 2024, KIT Plugins' NOIZ Hub series was created with the aim of providing a range of professio...
01/07/2025
New self-paced learning programme announced
Mastering.com have announced the availability of a new online course designed to cover the fundamentals of maste...
01/07/2025
The Traitors are coming: Get your first taste of the global hit as Season 1 of T...
01/07/2025
cetecom advanced certifies Rohde & Schwarz test solution for the verification of...
01/07/2025
RT has announced that Teresa Smith has been appointed Commissioning Editor with responsibility for Factual Entertainment following a public competition. This s...
Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer's disease Scripps Research scientists created a stable form of carnosic acid, observing greater memory function and other disease improvements in mice. 
